“A beacon of hope for relapsed multiple myeloma patients: TALVEY™”

“A beacon of hope for relapsed multiple myeloma patients: TALVEY™”

Bibliographic Details
Main Authors:	Nawal Khaliq, Rumaisa Riaz, Aleeza Hasan, Sara Alauddin
Format:	Article
Language:	English
Published:	SAGE Publishing 2023-09-01
Series:	Rare Tumors
Online Access:	https://doi.org/10.1177/20363613231205749

Similar Items

Adoptive NK Cell Therapy - a Beacon of Hope in Multiple Myeloma Treatment
by: Son Hai Vu, et al.
Published: (2023-11-01)

DOSTARLIMAB: A BEACON OF HOPE FOR CANCER PATIENTS
by: Abdul Haseeb Sahibzada, et al.
Published: (2022-12-01)

Elrexfio™ (elranatamab-bcmm): The game-changer in treatment of multiple myeloma
by: Taruba Rais, et al.
Published: (2023-10-01)

Unexpected hope for a multiple myeloma patient
by: Minodora Cezarina Onisâi, et al.
Published: (2020-10-01)

PARP inhibitors in gastric cancer: beacon of hope
by: Yali Wang, et al.
Published: (2021-06-01)

NORD. A beacon of hope for people with rare disorders
by: Stefanie Putkowski
Published: (2010-04-01)

Detection of early relapse in multiple myeloma patients
by: Tereza Růžičková, et al.
Published: (2025-01-01)

Bendamustine in patients with relapsed or refractory multiple myeloma
by: Michael M, et al.
Published: (2010-01-01)

H-FABP: A beacon of hope for prediabetic heart disease
by: Priyamvadha Ramesh, et al.
Published: (2020-01-01)

Immunotherapy for multiple myeloma: new chances and hope
by: Jingyu Xu, et al.
Published: (2023-10-01)

Monoclonal Antibodies in Relapsed-Refractory Multiple Myeloma
by: Ilaria Sorgiovanni, et al.
Published: (2025-01-01)

Pleural plasmacytomas in a Patient with Multiple Myeloma Relapse
by: Harith A. Al-Ataby
Published: (2023-05-01)

Pleural plasmacytomas in a patient with multiple myeloma relapse
by: Harith Al-Ataby, et al.
Published: (2022-01-01)

Asymptomatic leishmaniasis in a patient with relapsed multiple myeloma
by: Lucia Rubio, et al.
Published: (2021-08-01)

Lenalidomide for relapsed or refractory multiple myeloma
by: S. S. Bessmeltsev1, et al.
Published: (2014-07-01)

Treatment of relapsed and refractory multiple myeloma
by: Pieter Sonneveld, et al.
Published: (2016-08-01)

Treatment of relapsed and refractory multiple myeloma
by: Pieter Sonneveld, et al.
Published: (2016-04-01)

Ixazomib in the treatment of relapsed multiple myeloma
by: S. V. Semochkin
Published: (2018-07-01)

Lenalidomide for relapsed or refractory multiple myeloma
by: S. S. Bessmeltsev1, et al.
Published: (2014-07-01)

Cutaneous involvement in relapsed multiple myeloma
by: Valéry Salle, et al.
Published: (2022-09-01)

Carfilzomib for relapsed and refractory multiple myeloma
by: Groen K, et al.
Published: (2019-04-01)

Selinexor in relapsed/refractory multiple myeloma
by: Joshua Richter, et al.
Published: (2020-06-01)

Relapsed/Refractory Multiple Myeloma: A Review of Available Therapies and Clinical Scenarios Encountered in Myeloma Relapse
by: Parva Bhatt, et al.
Published: (2023-02-01)

Selinexor, daratumumab, and dexamethasone in patients with relapsed or refractory multiple myeloma
by: Cristina Gasparetto, et al.
Published: (2021-02-01)

Chromothripsis 18 in multiple myeloma patient with rapid extramedullary relapse
by: Jan Smetana, et al.
Published: (2018-01-01)

The role of belantamab mafodotin for patients with relapsed and/or refractory multiple myeloma
by: Melody R. Becnel, et al.
Published: (2020-12-01)

Relapse of Multiple Myeloma Presenting with Biliary Obstruction
by: Alan Coss, et al.
Published: (2010-01-01)

Multiple myeloma with central nervous system relapse
by: Philip A. Egan, et al.
Published: (2020-07-01)

Lenalidomide for the treatment of relapsed and refractory multiple myeloma
by: van de Donk NW, et al.
Published: (2012-08-01)

The role of carfilzomib in relapsed/refractory multiple myeloma
by: Andrew J. Yee
Published: (2021-06-01)

CENTRAL NERVOUS SYSTEM RELAPSE OF MULTIPLE MYELOMA
by: Maria Qubtia, et al.
Published: (2019-03-01)

Autotransplants in older multiple myeloma patients: hype or hope in the era of novel agents?
by: Monika Engelhardt, et al.
Published: (2016-11-01)

Is There a Role for Daratumumab Retreatment in Patients with Relapsed/Refractory Multiple Myeloma?
by: Davor Galusic, et al.
Published: (2025-01-01)

Giant retrocrural plasmacytoma as a relapse of multiple myeloma
by: Afef Feki, et al.
Published: (2022-08-01)

Relapse of Multiple Myeloma Presenting as Extramedullary Plasmacytomas in Multiple Organs
by: Murat Köse, et al.
Published: (2015-01-01)

Spiral of Decline or “Beacon of Hope:” Stories of School Choice in a Dual Language School.
by: Timothy Marc Pearson, et al.
Published: (2015-03-01)

Efficacy of lenalidomide, bortezomib, and prednisolone in patients with relapsed or refractory multiple myeloma
by: T. A. Мitinа, et al.
Published: (2015-12-01)

Hemostatic effects of bortezomib treatment in patients with relapsed or refractory multiple myeloma
by: Maurizio Zangari, et al.
Published: (2008-06-01)

PB2140: EVALUATION OF EARLY RELAPSE IN MULTIPLE MYELOMA (MM) PATIENTS
by: Annita-Ioanna Gkioka, et al.
Published: (2023-08-01)

The patient experience of relapsed refractory multiple myeloma and perspectives on emerging therapies
by: Rebecca Crawford, et al.
Published: (2022-11-01)